Leflunomide-induced acute hepatitis.
D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D000837:Anion Exchange Resins / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D002792:Cholestyramine Resin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000077339:Leflunomide; D008099:Liver / Q000473:pathology
D000276:Adjuvants, Immunologic; D000837:Anion Exchange Resins; D007555:Isoxazoles; D002792:Cholestyramine Resin; D000077339:Leflunomide